Introduction
Much of the regulation of eukaryotic gene expression is at the level of initiation of transcription. RNA polymerases themselves lack sequence-speci®c DNA-binding properties. A fundamental step in gene activation, therefore, is the assembly of transcription pre-initiation complexes at the gene promoter that ultimately lead to the recruitment of the enzyme. How is speci®city of RNA polymerase recruitment achieved?
In prokaryotes, the interaction between a distinct s factor and bacterial core RNA polymerase confers promoter selectivity to the resulting holoenzyme (Gross et al., 1992) . In eukaryotes, three nuclear RNA polymerases (Pol I, II and III) are responsible for the expression of distinct sets of genes. The mechanisms of speci®c recruitment are known for Pol II and Pol III. In the transcription of protein-coding genes by Pol II, the general transcription factor TFIIB was found to be essential in linking Pol II to the core promoter binding factor TFIID, a TBP±TAF (TBP-associated factor) complex (for review see Orphanides et al., 1996) . It was subsequently recognized that the general transcription factor TFIIIB, also an assembly of TBP and TAFs, determines Pol III recruitment and, interestingly, contains a TFIIB-related protein (BRF) which contacts subunits of Pol III (Chedin et al., 1998; Kumar et al., 1998) . Archaea also possess a homologue of the eukaryotic TFIIB, termed TFB, which functions together with the archaeal TBP to direct transcription by RNA polymerase (Bell and Jackson, 1998) . So, what determines recruitment of Pol I to the rRNA gene promoters in mammalian cells?
In human cell-free systems, two transcription factors have been identi®ed that are required for high levels of accurate initiation of transcription from the rRNA gene promoter: (i) selectivity factor SL1, a TBP±TAF I complex essential for transcription initiation (Learned et al., 1985; Bell et al., 1988; Comai et al., 1992 Comai et al., , 1994 Zomerdijk et al., 1994; Beckmann et al., 1995; Zomerdijk and Tjian, 1998) and (ii) upstream binding factor (UBF), a multiple HMG box-containing architectural protein and activator of Pol I transcription (Learned et al., 1986; Bell et al., 1988; Jantzen et al., 1990; Reeder et al., 1995) . These two transcription factors were found to interact cooperatively, and support ef®cient recruitment and initiation of transcription by Pol I (Bell et al., 1988) . Given the genic and functional conservation of the TFIIB proteins in transcriptional mechanisms in Archaea and eukaryotes, it came as somewhat of a surprise not to ®nd polypeptides with homology to TFIIB in the cloned subunits of SL1 Zomerdijk et al., 1994) . Therefore, it remained unclear whether the crucial link between SL1 and Pol I was direct or perhaps mediated by another general transcription factor.
Here, we have identi®ed and functionally de®ned a factor essential for the recruitment of Pol I to rRNA gene promoters. Human RRN3 is the homologue of a transcription factor essential for Pol I-dependent transcription in Saccharomyces cerevisiae. In yeast, Rrn3p is associated with a small fraction of Pol I complexes that is competent for speci®c initiation of transcription, and is involved in growth control of Pol I transcription Keener et al., 1998; Milkereit and Tschochner, 1998) . Recent complementation studies in yeast with a human homologue of RRN3 have shown that RRN3 is functionally conserved between yeast and humans (Moore®eld et al., 2000) . However, the function of RRN3 remained unclear. We demonstrate that hRRN3 interacts directly with SL1 and, in addition, de®nes a distinct subpopulation of transcriptionally active and hRRN3 is essential in the SL1-mediated recruitment of RNA Polymerase I to rRNA gene promoters The EMBO Journal Vol. 20 No. 6 pp. 1373±1382, 2001 ã European Molecular Biology Organization initiation-competent Pol I. Thus, hRRN3 connects the polymerase to the promoter-selectivity factor SL1.
Results
Human Pol I is found in a complex of >1 MDa In the human cell-free system used for this study, the transcription factors SL1 and UBF were well de®ned and characterized, while the molecular composition of Pol I and possible associated factors have remained elusive. In order to study and understand the essential interactions during recruitment of Pol I by SL1, we extensively puri®ed Pol I from HeLa cell nuclear extracts as outlined in Figure 1A . The Superose 6 step in the puri®cation separates the three components that reconstitute accurate and ef®cient transcription initiation from the rDNA promoter. The majority of Pol I activity, as assayed in a reconstituted transcription assay with rDNA promoter, SL1 and UBF, eluted at 9.5±11 ml from the Superose 6 size-exclusion column ( Figure 1B , top panel). The presence of Pol I activity in the fractions correlated with detection of the largest subunit of human Pol I by a speci®c antiserum ( Figure 1B , bottom panel). The Superose 6 fractions did not support transcription in the absence of SL1. Extrapolating from the size standards run in parallel, we estimate that the majority of Pol I is in a complex of >1 MDa. No signi®cant alteration in the elution pro®le could be detected in experiments where we fractionated the nuclear extract at salt concentrations as high as 0.5 M KCl, and the Pol I retention time at different¯ow rates remained constant (data not shown), suggesting that Pol I is part of a relatively stable and`globular' complex.
Two functionally distinct Pol I enzyme complexes The peak fractions from the Superose 6 column that displayed Pol I activity were pooled and subjected to chromatography on DEAE and SP Sepharose ionexchange columns. When subsequently subjected to af®nity chromatography on Poros Heparin, Pol I fractionated in two closely eluting forms, named Pol I a and b. Pol I b (in fractions 33±38 at 0.42 M KCl) supported speci®c initiation of transcription on the rDNA promoter when supplemented with UBF and SL1 ( Figure 1C , top panel). Immunodetection of the largest subunit of Pol I indicated that Pol I b constituted <10% of the total soluble pool of Pol I ( Figure 1C , bottom panel), and similarly the non-speci®c transcription activity for Pol I b was~10% of that of total Pol I (data not shown). The majority of Pol I, Pol I a (in fractions 28±32 at 0.39 M KCl), did not support speci®c initiation on a rRNA gene promoter template ( Figure 1C , top panel), yet displayed non-speci®c RNA synthesis activity on sheared calf thymus DNA. We propose that the Pol I a fraction is distinct from the DNAbound polymerases engaged in elongation of transcription, which appear not to extract from the nuclei under the conditions used. Mixing of Pol I a with Pol I b neither inhibited the activity of Pol I b nor activated Pol I a ( Figure 1D ), suggesting that the inability of Pol I a to support speci®c initiation is not due either to the presence of an excess of a trans-acting inhibitor in the Pol I a fractions or to the lack of a trans-activator. Samples from fractions (0.5 ml) of the Superose 6 column were tested in a speci®c transcription assay with the rDNA promoter, supplemented with SL1 and UBF, and transcripts were detected by S1 nuclease protection (arrowhead). The largest subunit of human Pol I, hA190, was detected in the same elution volumes from the Superose 6 column in immunoblots with anti-A190 antibodies. Size standards for the Superose 6 column are indicated above the lanes. (C) Poros Heparin columns separate Pol I a and b. The bulk of Pol I, Pol I a, is in fractions 28±32 as revealed with anti-A190 antibodies on immunoblots (bottom panel). The second peak of Pol I, Pol I b in fractions 34±36, constitutes a minor fraction of the total`soluble' Pol I, yet in a reconstituted transcription assay with rDNA, SL1 and UBF support speci®c initiation of transcription (top panel; arrowhead) . Pol I a is inactive in that same assay. (D) Mixing of Pol I a and b peak fractions. Pooled peak fractions of Pol I a and b (in ml) from the Poros Heparin column were tested, separately (lanes 1, 2 and 5) or mixed (lanes 3 and 4) as indicated above the lanes, for their ability to support speci®c initiation of transcription with SL1, UBF and rDNA (arrowhead).
hRRN3 co-fractionates with the initiationcompetent form of Pol I, Pol I b We cloned the human homologue of RRN3 (see Materials and methods), which shows no sequence similarity to any other known gene in the databases, and studied its function in Pol I-dependent transcription. We demonstrate that hRRN3 is associated exclusively with the initiationcompetent form of human Pol I, Pol I b.
The two forms of human Pol I from the Poros Heparin column were puri®ed further by subjecting them separately to chromatography on a Mono S column (Figure 2A ). Pol I elution was followed in a non-speci®c transcription assay with fractions from this column ( Figure 2B ). A peak of Pol I a activity appeared in fractions 18±21 (at 260 mM KCl; Figure 2B , left panel), and of Pol I b in fractions 21±24 (at 280 mM KCl; Figure 2B , right panel). It should be noted that the ratio of Pol I a and b, as found in the earlier steps of the puri®cation (see Figure 1B) , was the same at each chromatographic step, with Pol I a~10 times more abundant than Pol I b, indicating that this puri®cation did not convert one form into the other. As we have shown for the cruder fractions of Pol I a ( Figure 1C ), the Mono S fractions for this polymerase complex were inactive on the rDNA promoter in a reconstituted transcription assay containing SL1 and UBF (data not shown). In contrast, the Pol I b fractions from the Mono S column support high levels of speci®c initiation of transcription ( Figure 2C ).
Anti-peptide antibodies to hRRN3 were raised, peptide af®nity puri®ed and tested for speci®city ( Figure 2D ). The antibodies speci®cally bind to a 74 kDa protein in HeLa nuclear extracts, the predicted size for hRRN3 ( Figure 2D , lane 5). The antibodies also recognize a recombinant glutathione S-transferase (GST)±hRRN3 fusion protein ( Figure 2D , compare lanes 1 and 3). Having validated their speci®city, protein blots of peak fractions from the Mono S column of Pol I a and b were probed for the presence of hRRN3. Clearly, a fraction of the cellular hRRN3 cofractionated precisely and exclusively with Pol I b ( Figure 2E ). Although Pol I a and b can be separated on Heparin and Mono S columns, they elute at salt concentrations very close to each other. It is, therefore, not surprising to ®nd a weak signal for hRRN3 from the`tail' of the Pol I b peak in the side-fractions of Pol I a ( Figure 2E , left panel). The presence of subunits of the core polymerase in the Pol I fractions was con®rmed with an antibody speci®c for the largest subunit of human Pol I (A190), an antibody speci®c for mouse polymerase associated factor 53 (PAF53), which cross-reacts with human PAF53, and with an antibody that we have raised against human AC19, a small polymerase subunit shared by Pol I and Pol III ( Figure 2E ).
Note that we have named the two Pol I forms Pol I a and b to distinguish them from the previously described Pol I species in mammalian cells (Pol I A and Pol I B ) (Gissinger et al., 1974; Schwartz and Roeder, 1974; Matsui et al., 1976) for two reasons. First, Pol I a and b were recovered from salt-extracted nuclei without nuclear disintegration, Note that the ratio of Pol I a and b remained the same throughout the puri®cation procedure, with Pol I a~10 times more abundant than Pol I b. (C) Fractions from the Mono S column for Pol I b were assayed in a reconstituted transcription assay with SL1, UBF and rDNA promoter (arrowhead). (D) Af®nity-puri®ed anti-peptide antibodies raised against hRRN3 react in immunoblots with both an Escherichia coli-expressed recombinant GST±hRRN3 fusion protein of 100 kDa (lane 1) and a single protein of 74 kDa, the predicted molecular weight for hRRN3, in HeLa cell nuclear extract (lane 5). (E) hRRN3 is speci®c for Pol I b, and is lacking in Pol I a. Immunoblots of peak fractions for Pol I a and Pol I b from the Mono S columns were probed with anti-human A190 (Pol I), anti-human RRN3, anti-mouse PAF53 and anti-human AC19 (subunit shared by Pol I and III) antibodies.
hRRN3 links Pol I to SL1 at rDNA promoter and therefore were likely to represent primarily the`free' pool of Pol I, whereas in the previous studies nuclei and nucleoli were sonicated in the presence of salt, and under those conditions both`free' and`transcriptionally engaged' polymerases had been recovered. Secondly, Pol I A , when compared with Pol I B , lacked the third largest subunit, PAF53 (Hanada et al., 1996) , whereas PAF53 is present in both Pol I a and b (see Figure 2E) .
Hence, the co-fractionation of hRRN3 through multiple chromatographic steps with the initiation-competent form of Pol I, Pol I b, and not with Pol I a, which shares many of the same core polymerase subunits, suggests a speci®c and tight association of hRRN3 with the Pol I b complex and, therefore, a role for this factor in accurate transcription initiation on the rDNA promoter.
hRRN3 in sub-nucleolar structures co-localizes with Pol I Pol I-dependent transcription is con®ned to a speci®c subcompartment of the nucleus, the nucleolus. To investigate the localization of hRRN3 in vivo, hRRN3 was expressed as an enhanced yellow¯uorescent protein (EYFP) fusion in HeLa cells. EYFP±hRRN3 was observed as bright dots in nucleoli and as a diffuse signal in the nucleoplasm ( Figure 3A , left panel). An antibody speci®c for the second largest subunit of Pol I (A127) detected both forms of the enzyme, and a co-localization of nucleolar hRRN3 with a fraction of Pol I in substructures in the nucleolus can be observed ( Figure 3A , right and middle panel).
hRRN3 in Pol I holoenzymes including SL1 and UBF When EYFP±hRRN3 in extracts from transfected HEK293 cells was immunoprecipitated with an antibody speci®c for the¯uorescent protein tag, a small fraction of Pol I (~1.5%) was found associated with hRRN3 ( Figure 3B , lane 6). In the control experiment with EYFP-transfected cells, this co-immunoprecipitation was not observed ( Figure 3B , lane 2). Therefore, these results are in agreement with the in vivo co-localization and the chromatographic co-fractionation of hRRN3 with Pol I, and taken together the data suggest strongly that hRRN3 is tightly associated with Pol I. Interestingly, a small fraction of SL1 co-immunoprecipitated with hRRN3 ( Figure 3C , compare lanes 6 and 2), and UBF1, though little of UBF2, Fig. 3 . hRRN3 co-localizes and co-immunoprecipitates with Pol I and is found in a complex with SL1 and UBF. (A) Imaging of EYFP±hRRN3 expression (green) in transfected HeLa cells and of the Pol I second largest subunit (A127, red), reveals co-localization in sub-nucleolar structures (merged image in the middle, where yellow indicates co-localization). Scale bar, 10 mm. (B) Extracts (2.7 mg) from HEK293 cells transfected with EYFP (lanes 1±3) and EYFP±hRRN3 (lanes 5±7) expression constructs were immunoprecipitated with anti-GFP antibodies. Immunocomplexes were subjected to SDS±PAGE, immunoblotted and probed with an antibody speci®c for human A190 (Pol I largest subunit). Forty micrograms of the input (lanes 1 and 5) and supernatant (sup) after the immunoprecipitations (lanes 3 and 7) were loaded, and these, therefore, represent~1.5% of the total protein subjected to immunoprecipitation. As a marker, we loaded highly puri®ed Pol I (lane 4). Essentially the same immunoprecipitation results were obtained (data not shown) when the precipitations were performed in the presence of high concentrations (200 mg/ml) of ethidium bromide (Lai and Herr, 1992) . (C) The immunoprecipitates of (B) were analysed for SL1 subunits with antibodies speci®c for TAF I 63 Zomerdijk et al., 1994) and a mouse monoclonal antibody, SL39, against human TBP, both at 1:1000. Input and supernatant are as in (B). Highly puri®ed SL1 was loaded as a marker (lane 4). Note the slightly different mobilities of SL1 subunits in the relatively pure protein samples (lanes 4 and 6) compared with those in complex protein mixtures (lanes 5 and 7). (D) The immunoprecipitates of (B) were analysed in parallel for Pol I largest subunit A190, and UBF1 and 2. Anti-UBF antibodies (1:1000) were in a rabbit polyclonal serum. (E) Nuclear extracts prepared from HEK293 cells transfected with EYFP and EYFP±hRRN3 expression plasmids were tested for speci®c transcription initiation activity on the rDNA promoter (lanes 1 and 2). Anti-GFP-immunoprecipitated complexes from these nuclear extracts were transcriptionally active upon the addition of rRNA gene promoter template DNA and ribonucleoside triphosphates (lane 4). In the absence of added rDNA template, no transcription was observed (data not shown) and the immunoprecipitate from the EYFP-transfected cells was inactive (lane 3).
was also found in a complex with hRRN3 ( Figure 3D , compare lanes 4 and 2). The transfected EYFP±hRRN3 fusion protein stimulated Pol I transcription in extracts derived from these cells (up to 5-fold stimulation), suggesting a positive function for hRRN3 in transcription by Pol I ( Figure 3E, lanes 1 and 2) . Remarkably, the antigreen¯uorescent protein (GFP)-immunoprecipitated complexes from the EYFP±hRRN3-transfected cells were able to support speci®c initiation of transcription when rDNA and nucleotides were provided to these complexes, which were still bound to immobilized antibodies ( Figure 3E , compare lanes 4 and 3). Thus, EYFP±hRRN3 is functional, and these results suggest the presence of immunopuri®ed, transcriptionally autonomous protein assemblies, which are characteristic for Pol I holoenzyme complexes (SaezVasquez and Pikaard, 1997; Seither et al., 1998; Albert et al., 1999; Hannan et al., 1999 ).
hRRN3 interacts with SL1 Next we asked whether or not hRRN3 could bind SL1 and/ or UBF directly. To study such interactions, we used an af®nity resin of GST±hRRN3 puri®ed on glutathione± Sepharose from Escherichia coli extracts ( Figure 2D , lane 3). No detectable direct interaction between hRRN3 and highly puri®ed and recombinant UBF1 could be observed (data not shown). Interestingly, highly puri®ed human SL1 (see Materials and methods; J.K.Friedrich and J.C.B.M.Zomerdijk, unpublished data) was retained speci®cally on this af®nity resin, suggesting a direct interaction between hRRN3 and SL1 in the absence of Pol I ( Figure 4A , compare lanes 4 and 2). The direct interaction between hRRN3 and SL1 was further substantiated in an experiment where we ®rst immunoprecipitated SL1 with anti-TBP monoclonal antibodies from the already highly puri®ed SL1 fraction, and used this as an af®nity resin to capture FLAG-peptide af®nity-puri®ed, radiolabelled hRRN3 produced in reticulocyte lysates. Indeed, hRRN3 showed a signi®cant interaction with the anti-TBP resin pre-incubated with SL1 ( Figure 4B , compare lanes 4 and 3), under conditions where no speci®c interaction between radiolabelled luciferase and immunocomplexed SL1 was detectable ( Figure 4B , lane 5). Incubation of radiolabelled hRRN3 with renatured SL1 on a PVDF membrane revealed an interaction between hRRN3 and two polypeptides in the SL1 fraction. These proteins were identi®ed with SL1 subunit-speci®c antibodies as TAF I 110 and TAF I 63 ( Figure 4C ). Consistent with this observed direct interaction, GST af®nity chromatography showed binding of these TAF I subunits speci®cally to the GST±hRRN3 fusion protein.
hRRN3 is essential for the recruitment of Pol I by SL1 to the rDNA promoter Recently, in a yeast two-hybrid analysis, an interaction between yeast Rrn3 and Rrn6, a component of yeast core factor (CF), has been described (Peyroche et al., 2000) . CF ful®ls a function similar to metazoan SL1, and therefore, taken together with the data presented here, the functionally conserved RRN3 protein (Moore®eld et al., 2000) may serve to recruit Pol I to the promoter by interacting with a promoter-selective transcription factor in yeast and human. Here, we have tested this directly for mammalian Pol I-dependent transcription. We asked whether or not hRRN3 links Pol I to SL1 at rDNA promoter antibodies speci®c for hRRN3 could inhibit the recruitment of Pol I by SL1 on an immobilized rDNA promoter template. No signi®cant Pol I binding to the template could be observed in the absence of SL1 or with Pol I a (data not shown). In a comparison with control antibodies ( Figure 5A , lane 1), af®nity-puri®ed anti-hRRN3 antibodies clearly blocked the recruitment of Pol I b to SL1-bound promoter DNA in a dose-dependent manner ( Figure 5A, lanes 2 and 3) . The loss of recruitment of Pol I b to promoter-bound SL1 could be a consequence of the hRRN3 antibody interfering with the interaction between hRRN3 and SL1. To study this, we af®nity puri®ed radiolabelled hRRN3 and tested it for its ability to bind promoter-bound SL1. A speci®c interaction between promoter-bound SL1 and hRRN3 was observed ( Figure 5B, lanes 3 and 4) . This is consistent with the interaction we observed between GST±hRRN3 and free SL1 (see Figure 4A, lane 4) , and between af®nity-puri®ed, radiolabelled hRRN3 and immunoprecipitated SL1 (see Figure 4B , lane 4). Human RRN3 did not bind DNA in the absence of SL1 ( Figure 5B , lane 5). Importantly, whereas control antibodies had no effect ( Figure 5B , lane 6), antihRRN3 antibodies completely blocked the binding of hRRN3 to SL1 at the promoter ( Figure 5B, lane 7) . Protein blots con®rmed that SL1 was present on the immobilized promoter template ( Figure 5C, lanes 2 and 3) and that the antibody-induced loss of hRRN3 binding to SL1 on the immobilized template was not due to loss of SL1 from the template ( Figure 5C, lanes 4 and 5) . Taken together, these results strongly suggest an essential role for hRRN3 in the recruitment of Pol I by SL1, as it provides a direct link between these components.
The anti-hRRN3 antibodies, therefore, should affect speci®c transcription initiation. Indeed, antibodies speci®c for hRRN3 inhibit Pol I transcription ( Figure 5D , lanes 3±5), but do not affect non-speci®c transcription (data not shown). In agreement with targeting of Pol I b by the hRRN3 antibodies and interference with the Pol I recruitment, an excess of Pol I b (which by itself cannot support transcription; Figure 5D , lane 10) restored transcription initiation in the antibody-inhibited transcription reaction ( Figure 5D , compare lane 9 with 8). Fig. 5 . hRRN3 is essential for the SL1-mediated recruitment of Pol I to the rDNA promoter. (A) Af®nity-puri®ed antibodies against hRRN3, in a dose-dependent manner, prevent the recruitment of Pol I b to SL1, which was pre-bound to the rDNA promoter. Immobilized rDNA promoter template DNA (IT-DNA) was pre-incubated for 30 min with highly puri®ed SL1 and, in parallel, a 0.2 M KCl fraction from DEAE columns, named D0.2, and containing UBF and initiation-competent Pol I (Comai et al., 1992) , was pre-incubated for 30 min with af®nity-puri®ed anti-hRRN3 antibodies (4 and 8 mg, lanes 2 and 3, respectively) or control sheep IgG antibodies (8 mg, lane 1). The immobilized templates were washed in TM10/0.05 M KCl to remove unbound SL1, and then added to the UBF/Pol I/antibody mixture. This reaction was incubated for a further 20 min, after which the immobilized templates were washed in TM10/0.05 M KCl. Templatebound proteins were eluted in 10 M urea at room temperature and analysed by immunoblotting with antibodies speci®c for human A190, TAF I 110 Zomerdijk et al., 1994) and TBP. (B) Antibodies speci®c for hRRN3 block the binding of highly puri®ed hRRN3 to SL1 pre-bound to the rDNA promoter. Immobilized rDNA promoter template DNA was pre-incubated for 20 min with either 5 or 10 ml of highly puri®ed SL1 (lanes 3 and 4, respectively) or without SL1 (lane 5). Templates were washed and mixed with FLAG-epitope af®nity-puri®ed, 35 S-radiolabelled hRRN3. In a separate experiment, the puri®ed 35 S-radiolabelled hRRN3 had been pre-incubated for 20 min with peptide af®nity-puri®ed anti-hRRN3 antibodies (8 mg, lane 7) or IgG (8 mg, lane 6) before addition to promoter-bound SL1. The reactions were incubated for 20 min and then the templates were washed. The template-bound proteins were eluted in urea and subjected to SDS±PAGE. The gel was ®xed, dried and subjected to autoradiography to reveal [ 35 S]FLAG-hRRN3. Lanes 1 and 2 are 10 and 20%, respectively, of the input of [ 35 S]FLAG-hRRN3. In the absence of SL1, hRRN3 did not bind the promoter DNA template (lane 5). (C) The binding of SL1 to the immobilized template (IT-rDNA) from the experiment described in (B) was veri®ed by immunoblotting the reactions of lane 3 and 4 of (B) with antibodies speci®c for two subunits of SL1, TAF I 110 and TBP (lanes 2 and 3). SL1 input (5 ml) is shown (lane 1). Antibodies speci®c for hRRN3 did not displace SL1 from the immobilized rDNA promoter template (lanes 4 and 5). Reactions were performed as described in (B) for lanes 6 and 7. (D) Inhibition of Pol I transcription with af®nity-puri®ed anti-hRRN3 antibodies (2, 4 and 8 mg, lanes 3±5, respectively), but not with control IgG (4 and 8 mg, lanes 1 and 2, respectively). The experimental procedure was as outlined in (C), except that templatebound proteins were not eluted, but rather tested for their ability to support speci®c initiation of transcription upon addition of ribonucleoside triphosphates in a 30 min reaction. Transcripts were detected in an S1 nuclease protection assay (arrowhead). Lane 6 is a control transcription reaction in the absence of antibodies. Supplementing a reaction with 2.5 ml of Pol I b recovers anti-hRRN3 antibody-induced inhibition of transcription. Lane 8 illustrates the inhibition of transcription with 4 mg of af®nity-puri®ed anti-hRRN3 antibodies, and add-back of Pol I b restores transcription (lane 9). Control reactions were loaded in lane 7 (no antibodies) and lane 10 (no SL1 and UBF in the reaction), illustrating that Pol I b by itself does not support speci®c initiation of transcription.
Discussion
The essential role of hRRN3 in the SL1-mediated recruitment of Pol I to rRNA gene promoters We provide several lines of evidence for an essential function of the Pol I transcription factor hRRN3 in the SL1-mediated recruitment of Pol I to rRNA gene promoters. We have shown a stable, speci®c and selective association of hRRN3 with a subpopulation of Pol I, Pol I b, which supported SL1-dependent and promoter-directed initiation of transcription. Our results, and those in the mouse, Acanthamoeba and S.cerevisiae systems, therefore illustrate an apparent evolutionary conservation in eukaryotes of the apportionment of Pol I into two functionally distinct forms (Bateman and Paule, 1986; Tower and Sollner-Webb, 1987; Milkereit and Tschochner, 1998) . In extracts from transfected cells, a tagged version of the hRRN3 protein co-immunoprecipitated with SL1, UBF1 and Pol I, and these immunopuri®ed complexes supported accurate initiation of transcription from rDNA promoter templates. Furthermore, we have demonstrated an interaction between SL1 and hRRN3, as demonstrated in several protein±protein interaction assays where either of the interacting partners was used as an af®nity resin. For example, hRRN3 was retained speci®cally on highly puri®ed SL1 tethered by anti-TBP antibodies and on SL1 pre-bound to an immobilized promoter DNA template, and conversely SL1 interacted with tethered recombinant hRRN3 GST fusion proteins on glutathione±agarose. Far-western analyses supported the notion of a direct interaction of hRRN3 with SL1, since renatured TAF I 110 and TAF I 63 subunits of SL1 interacted with radiolabelled hRRN3, and indeed these same TAF I s interacted with GST±hRRN3 in pull-down assays. Antibodies speci®c for hRRN3 prevented the interaction between hRRN3 and SL1, and an excess of Pol I±hRRN3 complex (Pol I b) when added back reversed this inhibition. These experiments explain at a molecular level how the hRRN3-speci®c antibody both inhibits transcription initiation and abolishes the recruitment of Pol I to an SL1-engaged promoter rDNA template. Therefore, we propose that the interaction of hRRN3 with SL1 is essential for the recruitment of mammalian Pol I by SL1 at the rRNA gene promoter. This correlates well with the suggested role for yeast Rrn3p in bridging polymerase to CF (Peyroche et al., 2000) , and taken together these results signify an apparent similarity in the mechanism of Pol I recruitment in yeast and metazoans.
Stepwise assembly and Pol I holoenzyme recruitment Our results are compatible with two pathways for the assembly of transcription pre-initiation complexes, as outlined in Figure 6 . In one scenario, Pol I b is directly recruited to the rDNA promoter as a result of a productive interaction between polymerase-associated hRRN3 and promoter-bound SL1. In the second, an interaction between SL1 and hRRN3 in Pol I b leads to the formation of a holoenzyme complex, which may include UBF, and this pre-assembled complex then binds the rDNA promoter. Since SL1 remains at the promoter following escape by Pol I from the rDNA promoter (Panov et al., 2001) , the frequent re-initiations of Pol I transcription are likely to follow the former pathway. Indeed, the predominant form of the initiation-competent form of Pol I in the nucleus is Pol I b, with only very low levels of it in holoenzyme complexes, which were detectable only after af®nity puri®cation from cell extracts that overexpressed tagged hRRN3 (Figure 3) . The transcriptional autonomy of the af®nity-puri®ed complexes ®ts with the proper de®nition of polymerase holoenzymes, which support accurate initiation of transcription from promoter DNA templates in the absence of accessory factors.
Regulation of Pol I transcription by interconversion of Pol I a and b There is evidence in S.cerevisiae to suggest a role for RRN3 in growth control, and the proposed molecular mechanism intimated a differential association of RRN3 with the initiation-competent form of Pol I (Milkereit and Tschochner, 1998) . The mouse homologue of yeast RRN3 has recently been identi®ed as TIF-IA (Bodem et al., 2000) , a factor whose activity or abundance appears to be regulated under varying growth conditions (Buttgereit et al., 1985) . In addition, in both mammals and yeast, a large fraction of the polymerase in the nucleus, here named Pol I a, is unable to support speci®c initiation, despite its ability to synthesize RNA from non-speci®c templates. The function for hRRN3 de®ned here allows us to explain at a molecular level the role of murine transcription factor TIF-IA (Buttgereit et al., 1985; Schnapp et al., 1990 Schnapp et al., , 1993 , otherwise known as Factor C* (Tower and Sollner-Webb, 1987; Brun et al., 1994) , in growth control of Pol I-dependent transcription. We propose a comprehensive model for the regulation of rRNA gene transcription at the level of polymerase recruitment, and suggest that growth control of Pol I transcription in mammalian cells involves the regulated interconversion between the Fig. 6 . A model for the role of hRRN3 in productive Pol I preinitiation complex formation at the rRNA gene promoters. hRRN3 has an essential function in linking Pol I to SL1 at the rDNA promoter and in Pol I holoenzyme complex assembly. hRRN3, speci®cally associated with the initiation-competent form of Pol I, Pol I b, interacts with SL1. Pol I a lacks hRRN3 and is not competent for productive interaction with SL1. The interaction of hRRN3 with SL1 may occur in solution, leading to the formation of a Pol I holoenzyme complex that displays promoter selectivity (during`de novo' pre-initiation complex assembly), and/or may take place at the rDNA promoter, where prebound SL1 recruits Pol I b via a crucial connection with hRRN3 (during re-initiation of transcription).
hRRN3 links Pol I to SL1 at rDNA promoter initiation-competent Pol I b and an inactive Pol I complex that lacks hRRN3, perhaps Pol I a (Figure 6 ). In this respect, it is interesting to note that we found a large fraction of the total cellular hRRN3 not associated with polymerases (data not shown); the nature of this hRRN3 and, perhaps, its associated factors is currently under investigation.
Stimulation of transcription initiation by recombinant hRRN3 can be observed in a nuclear extract, yet recombinant hRRN3 cannot simply convert highly puri®ed Pol I a into a promoter-competent Pol I b (data not shown). This suggests that in mammalian cells the interconversion of Pol I a to b may involve additional factors or, perhaps, modi®cations in addition to and/or required for the incorporation of hRRN3 into the polymerase complex. We note that other contacts between SL1 and polypeptides in Pol I b, and between UBF and Pol I (Schnapp et al., 1994; Hanada et al., 1996) , are likely to occur, but nevertheless the interaction between hRRN3 and SL1 is essential for the stable recruitment of the enzyme. Given the essential role for hRRN3 in linking the polymerase to SL1 in rRNA gene expression, the interactions between hRRN3 and SL1, and between hRRN3 and Pol I, are likely to be major targets of regulatory pathways that control`de novo' assembly of Pol I pre-initiation complexes at rDNA promoters, and Pol I recruitment during re-initiation of transcription.
hRRN3, like TFIIB, provides the bridge between polymerase and the promoter-selectivity factor A fundamental step in gene activation is the recruitment of RNA polymerase by promoter-bound factors, and general transcription factors with domains homologous to TFIIB function in this process, both in Archaea and eukaryotes. No TFIIB-like polypeptides were found in SL1 Zomerdijk et al., 1994) , and human and yeast RRN3 primary amino acid sequence analyses also failed to reveal homology with conserved domains in TFIIB. Yet hRRN3 emerges as functionally related to TFIIB, TFB and the BRF subunit of TFIIIB, since all of them are critically important in connecting polymerase to promoter-selectivity factors. Thus, we may de®ne hRRN3 as the`missing link' in Pol I-dependent transcription.
Materials and methods

Cloning and expression vectors of hRRN3
The original full-length cDNA clone of hRRN3 was isolated from a HeLa lTriplEx cDNA library (Clontech) and subcloned for GST, EYFP and FLAG-tagged expression (for details of identi®cation and cloning of hRRN3 see Supplementary data, available at The EMBO Journal Online).
Antibodies, immunoblotting, immunoprecipitation and immuno¯uorescence Peptides corresponding to the following sequences of hRRN3 were coupled to bovine serum albumin (BSA) (Merck BDH) and keyhole limpet haemocyanin (Calbiochem) to raise sheep antisera (Diagnostics Scotland): MAAPLLHTRLPGDAC, EKFPVRKSERTLEC and CGS-PPVLYMQPSPL. The same peptides were used to af®nity purify the antibodies.
Primary antibodies used were: anti-A190 (human Pol I largest subunit) antibodies (1:250), peptide-af®nity puri®ed from sheep immunized with a mixture of three peptides derived from the human A190 Pol I largest subunit (K.I.Panov and J.C.B.M.Zomerdijk, unpublished data); antihRRN3 af®nity-puri®ed sheep antibodies (1:1000); anti-PAF53 antibodies (1:1000) (Hanada et al., 1996) ; anti-AC19 antibodies (1:1000), a polyclonal sheep serum raised against recombinant human AC19 small subunit shared between Pol I and Pol III (G.Miller and J.C.B.M.Zomerdijk, unpublished data); anti-TAF I 110 (1:1000) and anti-TAF I 63 (1:2000) . Appropriate secondary antibodies conjugated to horseradish peroxidase (Jackson ImmunoResearch) were used to detect immunocomplexes on the blots by chemiluminescence (ECL; Amersham Pharmacia Biotech).
Immunoprecipitations were carried out from either whole-cell lysates or nuclear extracts. Human embryonic kidney (HEK) 293 cells were transfected using calcium phosphate with either EYFP (pEYFP-C1; Invitrogen) or EYFP±hRRN3 (pEYFP-C1±hRRN3; see Supplementary data) expression vectors. Cells were lysed 20 h post-transfection in 0.5 ml (per 10 cm plate) of 50 mM Tris±HCl pH 7.5, 0.5 M NaCl, 1% NP-40, 1% deoxycholate, 1% SDS, 2 mM EDTA, EDTA-free complete protease inhibitor cocktail (Roche). Each whole-cell lysate (2.7 mg) was precleared with 10 ml of protein G±Sepharose beads (Amersham Pharmacia) for 30 min at 4°C, and then used in immunoprecipitation experiments with 10 mg of anti-GFP antibodies (Roche) bound to 25 ml of protein G±Sepharose beads for 2 h at 4°C. The beads were washed four times in 1 ml of 50 mM Tris±HCl pH 7.5, 0.25 M NaCl, and precipitates were analysed by immunoblotting. Immunoprecipitations from the nuclear extracts were performed with 50 mg of each nuclear extract, which had been pre-cleared for 30 min with 10 ml of protein G±Sepharose beads, with 4 mg of anti-GFP antibodies bound to 7.5 ml of protein G±Sepharose beads in TM10/0.4 M KCl and 0.05% NP-40 for 3 h at 4°C. TM10 buffer is: 50 mM Tris±HCl pH 7.9, 12.5 mM MgCl 2 , 1 mM EDTA, 10% glycerol, 1 mM sodium metabisul®te and 1 mM dithiothreitol (DTT). Beads were washed four times in 1 ml of TM10/ 0.4 M KCl buffer and used in transcription assays.
EYFP±hRRN3 was transfected into HeLa cells using the effectene method (Qiagen). The cells were incubated for 20 h, washed in phosphate-buffered saline (PBS), then ®xed in 4% paraformaldehyde in PBS for 10 min, permeabilized with 0.1% Tween-20 in PBS for 10 min, and incubated with anti-A127 antibodies (1:50; speci®c for the second largest subunit of rat Pol I; Hannan et al., 1998) for 1 h at room temperature (RT). Subsequently, the slides were washed four times for 5 min in PBS at RT, incubated with anti-rabbit Texas Red secondary antibodies (1:250; Jackson ImmunoResearch) for 30 min at RT, and then washed in PBS, mounted in Mowiol/Dabco and allowed to dry. Cells were viewed using a Zeiss LSM 410 confocal laser scanning microscope.
GST-af®nity chromatography
Escherichia coli BL21 (DE3) cells were transformed with pGEX-4T-3-hRRN3 (see Supplementary data) or pGEX-4T-3 (Amersham Pharmacia). Cells were grown to an OD 600 nm of 0.6 and induced with 0.5 mM isopropyl-b-D-thiogalactopyranoside for 3 h at 37°C. Cells were harvested, resuspended in buffer T/0.15 M NaCl (buffer T: 50 mM Tris±HCl pH 7.9, 1 mM DTT, 1 mM phenylmethylsulfonyl¯uoride), sonicated and centrifuged at 15 000 g for 25 min at 4°C. The bacterial lysate was bound to 1 ml of glutathione±Sepharose beads (Amersham Pharmacia Biotech) for 1 h at 4°C. Beads were washed three times at 4°C for 10 min with 20 ml of buffer T/0.15 M NaCl, and then three times for 10 min with 20 ml of buffer T/1.0 M NaCl. Twenty microlitres of beads were used as af®nity resin in 600 ml of TM10/0.15 M KCl. The beads were blocked with 20 mg of BSA for 1 h, and then highly puri®ed SL1 was added and incubated for 2 h at 4°C. The beads were then washed in 600 ml of TM10/0.2 M KCl for 5 min at 4°C, followed by washes in TM10/0.25, TM10/0.3 and TM10/0.35 M KCl buffers. Bound proteins were analysed by immunoblotting.
TAF I 110 and TAF I 63 were in vitro translated and independently incubated with GST± or GST±hRRN3±beads. The pulldown with GST or GST±hRRN3 was carried out in 20 mM Tris±HCl pH 7.9, 100 mM KCl, 20% glycerol, 0.2 mM EDTA, 0.5% NP-40 for 2 h, followed by four 10-min washes with the same buffer. Bound proteins were analysed by SDS±PAGE and autoradiography.
In vitro translation and af®nity puri®cation of [ 35 S]FLAG-hRRN3 [ 35 S]FLAG-hRRN3 was synthesized from plasmid pcDNA3-FLAGhRRN3 (see Supplementary data; pcDNA3 was from Invitrogen) in a total reaction volume of 300 ml, in the TNT-coupled rabbit reticulocyte lysate system (Promega). Reactions were diluted with 1.2 ml of TM10/ 0.2 M KCl buffer. To af®nity purify the protein, 25 ml of anti-FLAG M2-beads (Kodak) were added and incubated, with shaking, overnight at 4°C. The beads were washed twice in 500 ml volumes of TM10/0.05, TM10/0.3, TM10/0.6 and TM10/0.1 M KCl buffers, and eluted in 50 ml of 1 mg/ml FLAG peptide in TM10/0.1 M KCl at 4°C for 4 h.
Far-western analysis
Highly puri®ed SL1 was subjected to SDS±PAGE and transferred to an Immobilon-P (Millipore) membrane.The membrane was probed with FLAG-puri®ed, [ 35 S]methionine-labelled hRRN3, as described (Kaelin et al., 1992) , and with antibodies speci®c for TAF I 110 and TAF I 63 .
In vitro transcription assays
In vitro transcription reactions were performed as described previously (Learned et al., 1986; Bell et al., 1988) at a ®nal salt concentration of 50±70 mM KCl. Supercoiled prHu3 plasmid DNA, which contains the human rRNA gene promoter from ±515 to +1548 (Learned and Tjian, 1982) , or immobilized linear DNA fragments were used as templates in the transcription reaction. The resulting transcripts were analysed in an S1 nuclease protection assay after annealing the RNA to a 5¢-end-labelled oligonucleotide, which was identical to the region between ±20 and +40 of the promoter template strand (Bell et al., 1988) . For the non-speci®c transcription assay and preparation of the immobilized template see Supplementary data.
Puri®cation of Pol I complexes and SL1 from HeLa cell nuclear extracts Pol I was puri®ed from HeLa cell nuclei (Figures 1 and 2) by passage over Superose 6, DEAE±Sepharose and SP Sepharose, and separated into Pol I a and b on Poros Heparin and Mono S columns. For a detailed protocol see Supplementary data. Pol I a and b were free from SL1 and UBF.
SL1 was puri®ed from HeLa nuclear extract on heparin±agarose and S-Sepharose columns , followed by chromatography on Poros Heparin and Superose 6 columns (see Supplementary data). SL1 fractions were identi®ed by in vitro transcription assays. SL1 was free from Pol I and UBF. In Figure 4B , SL1 was immunopuri®ed with anti-TBP monoclonal antibodies (SL39; kindly provided by N.Hernandez). Protein G±Sepharose-pre-cleared SL1 was incubated overnight at 4°C with the protein G-bound, anti-TBP antibody. Beads were washed extensively with several changes of 1 ml TM10/0.3 before equilibration to TM10/0.05.
Supplementary data
Supplementary data for this paper are available at The EMBO Journal Online.
